191 related articles for article (PubMed ID: 35523582)
1. Inhibition of Crmp1 Phosphorylation at Ser522 Ameliorates Motor Function and Neuronal Pathology in Amyotrophic Lateral Sclerosis Model Mice.
Asano T; Nakamura H; Kawamoto Y; Tada M; Kimura Y; Takano H; Yao R; Saito H; Ikeda T; Komiya H; Kubota S; Hashiguchi S; Takahashi K; Kunii M; Tanaka K; Goshima Y; Nakamura F; Takeuchi H; Doi H; Tanaka F
eNeuro; 2022; 9(3):. PubMed ID: 35523582
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of collapsin response mediator protein-2 phosphorylation ameliorates motor phenotype of ALS model mice expressing SOD1G93A.
Numata-Uematsu Y; Wakatsuki S; Nagano S; Shibata M; Sakai K; Ichinohe N; Mikoshiba K; Ohshima T; Yamashita N; Goshima Y; Araki T
Neurosci Res; 2019 Feb; 139():63-68. PubMed ID: 30194029
[TBL] [Abstract][Full Text] [Related]
3. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
[TBL] [Abstract][Full Text] [Related]
4. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
5. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
[TBL] [Abstract][Full Text] [Related]
6. PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Ringer C; Büning LS; Schäfer MK; Eiden LE; Weihe E; Schütz B
Neurobiol Dis; 2013 Jun; 54():32-42. PubMed ID: 23466699
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of ALCAT1 mitigates amyotrophic lateral sclerosis by attenuating SOD1 protein aggregation.
Liu X; Zhang J; Li J; Song C; Shi Y
Mol Metab; 2022 Sep; 63():101536. PubMed ID: 35772643
[TBL] [Abstract][Full Text] [Related]
8. R13 preserves motor performance in SOD1
Li X; Chen C; Zhan X; Li B; Zhang Z; Li S; Xie Y; Song X; Shen Y; Liu J; Liu P; Liu GP; Yang X
Theranostics; 2021; 11(15):7294-7307. PubMed ID: 34158851
[TBL] [Abstract][Full Text] [Related]
9. Comparing effects of microgravity and amyotrophic lateral sclerosis in the mouse ventral lumbar spinal cord.
Yoshikawa M; Ishikawa C; Li H; Kudo T; Shiba D; Shirakawa M; Muratani M; Takahashi S; Aizawa S; Shiga T
Mol Cell Neurosci; 2022 Jul; 121():103745. PubMed ID: 35660087
[TBL] [Abstract][Full Text] [Related]
10. Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis.
Zhang Y; Ogbu D; Garrett S; Xia Y; Sun J
Gut Microbes; 2021; 13(1):1996848. PubMed ID: 34812107
[TBL] [Abstract][Full Text] [Related]
11. Novel insights into RAGE signaling pathways during the progression of amyotrophic lateral sclerosis in RAGE-deficient SOD1 G93A mice.
Nowicka N; Zglejc-Waszak K; Juranek J; Korytko A; Wąsowicz K; Chmielewska-Krzesińska M; Wojtkiewicz J
PLoS One; 2024; 19(3):e0299567. PubMed ID: 38457412
[TBL] [Abstract][Full Text] [Related]
12. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
[TBL] [Abstract][Full Text] [Related]
13. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
[TBL] [Abstract][Full Text] [Related]
14. Glycine receptor channels in spinal motoneurons are abnormal in a transgenic mouse model of amyotrophic lateral sclerosis.
Chang Q; Martin LJ
J Neurosci; 2011 Feb; 31(8):2815-27. PubMed ID: 21414903
[TBL] [Abstract][Full Text] [Related]
15. Persistent NRG1 Type III Overexpression in Spinal Motor Neurons Has No Therapeutic Effect on ALS-Related Pathology in SOD1
Hernández S; Salvany S; Casanovas A; Piedrafita L; Soto-Bernardini MC; Tarabal O; Blasco A; Gras S; Gatius A; Schwab MH; Calderó J; Esquerda JE
Neurotherapeutics; 2023 Oct; 20(6):1820-1834. PubMed ID: 37733208
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Krishnan J; Vannuvel K; Andries M; Waelkens E; Robberecht W; Van Den Bosch L
J Neurochem; 2008 Sep; 106(5):2170-83. PubMed ID: 18624915
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
[TBL] [Abstract][Full Text] [Related]
18. Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis.
Bros-Facer V; Krull D; Taylor A; Dick JR; Bates SA; Cleveland MS; Prinjha RK; Greensmith L
Hum Mol Genet; 2014 Aug; 23(16):4187-200. PubMed ID: 24667415
[TBL] [Abstract][Full Text] [Related]
19. Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice.
Turner BJ; Ackerley S; Davies KE; Talbot K
Hum Mol Genet; 2010 Mar; 19(5):815-24. PubMed ID: 20008901
[TBL] [Abstract][Full Text] [Related]
20. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
